Effect of whole soy and purified daidzein on ambulatory blood pressure and endothelial function-a 6-month double-blind, randomized controlled trial among Chinese postmenopausal women with prehypertension
Publication in refereed journal


Times Cited
Web of Science16WOS source URL (as at 14/07/2020) Click here for the latest count
Altmetrics Information
.

Other information
AbstractBACKGROUND/OBJECTIVES: Although observational studies suggest that soy foods or isoflavones are cardio-protective, clinical trials on whole soy or isoflavone daidzein (one major isoflavone and the precursor of equol) on blood pressure (BP) and endothelial function (EF) are few and have not been specifically conducted among equol producers, a population most likely to benefit from soy treatment.
All Author(s) ListLiu ZM, Ho SC, Chen YM, Tomlinson B, Ho S, To K, Woo J
Journal nameEuropean Journal of Clinical Nutrition
Year2015
Month10
Day1
Volume Number69
Issue Number10
PublisherNATURE PUBLISHING GROUP
Pages1161 - 1168
ISSN0954-3007
eISSN1476-5640
LanguagesEnglish-United Kingdom
Web of Science Subject CategoriesNutrition & Dietetics

Last updated on 2020-15-07 at 01:52